← Every company
Castle Biosciences Inc SEC Filings
What Castle Biosciences Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
CSTL overview →Filings on file
100
since Jun 26, 2019
Warning signs
1
latest Mar 5, 2020
Last results
Jul 30, 2026
8-K item 2.02
Industry
Services-Medical Laboratories
SIC 8071
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jul 30, 2026 | Quarterly report 10-Q | Read ↗ |
| Jul 30, 2026 | Results announced 8-K | Read ↗ |
| May 29, 2026 | Shareholder vote 8-K | Read ↗ |
| May 6, 2026 | Quarterly report 10-Q | Read ↗ |
| May 6, 2026 | Results announced 8-K | Read ↗ |
| Feb 26, 2026 | Annual report 10-K | Read ↗ |
| Feb 26, 2026 | Results announced 8-K | Read ↗ |
| Jan 13, 2026 | Results announced 8-K | Read ↗ |
| Nov 3, 2025 | Quarterly report 10-Q | Read ↗ |
| Nov 3, 2025 | Results announced 8-K | Read ↗ |
| Aug 4, 2025 | Quarterly report 10-Q | Read ↗ |
| Aug 4, 2025 | Results announced 8-K | Read ↗ |
| May 23, 2025 | Shareholder vote 8-K | Read ↗ |
| May 5, 2025 | Quarterly report 10-Q | Read ↗ |
| May 5, 2025 | Results announced 8-K | Read ↗ |
| Feb 27, 2025 | Annual report 10-K | Read ↗ |
| Feb 27, 2025 | Results announced 8-K | Read ↗ |
| Jan 13, 2025 | Results announced 8-K | Read ↗ |
| Nov 4, 2024 | Quarterly report 10-Q | Read ↗ |
| Nov 4, 2024 | Results announced 8-K | Read ↗ |
| Aug 5, 2024 | Quarterly report 10-Q | Read ↗ |
| Aug 5, 2024 | Results announced 8-K | Read ↗ |
| May 24, 2024 | Shareholder vote 8-K | Read ↗ |
| May 2, 2024 | Quarterly report 10-Q | Read ↗ |
| May 2, 2024 | Results announced 8-K | Read ↗ |
| Mar 27, 2024 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Feb 28, 2024 | Annual report 10-K | Read ↗ |
| Feb 28, 2024 | Results announced 8-K | Read ↗ |
| Jan 8, 2024 | Results announced 8-K | Read ↗ |
| Nov 9, 2023 | Executive or director change 8-K | Read ↗ |
| Nov 2, 2023 | Quarterly report 10-Q | Read ↗ |
| Nov 2, 2023 | Results announced 8-K | Read ↗ |
| Aug 2, 2023 | Quarterly report 10-Q | Read ↗ |
| Aug 2, 2023 | Results announced 8-K | Read ↗ |
| Jun 1, 2023 | Shareholder vote 8-K | Read ↗ |
| May 3, 2023 | Quarterly report 10-Q | Read ↗ |
| May 3, 2023 | Results announced 8-K | Read ↗ |
| Feb 28, 2023 | Annual report 10-K | Read ↗ |
| Feb 28, 2023 | Results announced 8-K | Read ↗ |
| Jan 20, 2023 | Executive or director change 8-K | Read ↗ |
| Jan 9, 2023 | Results announced 8-K | Read ↗ |
| Dec 28, 2022 | Executive or director change 8-K | Read ↗ |
| Dec 15, 2022 | Executive or director change 8-K | Read ↗ |
| Nov 2, 2022 | Quarterly report 10-Q | Read ↗ |
| Nov 2, 2022 | Results announced 8-K | Read ↗ |
| Aug 8, 2022 | Quarterly report 10-Q | Read ↗ |
| Aug 8, 2022 | Results announced 8-K | Read ↗ |
| Jun 8, 2022 | Shareholder vote 8-K | Read ↗ |
| May 9, 2022 | Quarterly report 10-Q | Read ↗ |
| May 9, 2022 | Results announced 8-K | Read ↗ |
| May 2, 2022 | Unregistered share sale 8-K | Read ↗ |
| Apr 7, 2022 | Material agreement 8-K | Read ↗ |
| Apr 4, 2022 | Material agreementUnregistered share sale 8-K | Read ↗ |
| Mar 17, 2022 | Material agreement 8-K | Read ↗ |
| Feb 28, 2022 | Annual report 10-K | Read ↗ |
| Feb 28, 2022 | Results announced 8-K | Read ↗ |
| Jan 10, 2022 | Results announced 8-K | Read ↗ |
| Jan 5, 2022 | Executive or director change 8-K | Read ↗ |
| Dec 6, 2021 | Acquisition or sale completedMaterial agreement 8-K | Read ↗ |
| Dec 3, 2021 | Material agreement 8-K | Read ↗ |
| Nov 8, 2021 | Quarterly report 10-Q | Read ↗ |
| Nov 8, 2021 | Results announced 8-K | Read ↗ |
| Oct 19, 2021 | Material agreement 8-K | Read ↗ |
| Aug 9, 2021 | Quarterly report 10-Q | Read ↗ |
| Aug 9, 2021 | Results announced 8-K | Read ↗ |
| Jul 16, 2021 | Executive or director change 8-K | Read ↗ |
| Jun 14, 2021 | Shareholder vote 8-K | Read ↗ |
| May 10, 2021 | Quarterly report 10-Q | Read ↗ |
| May 10, 2021 | Results announced 8-K | Read ↗ |
| Apr 9, 2021 | Executive or director change 8-K | Read ↗ |
| Mar 11, 2021 | Annual report 10-K | Read ↗ |
| Mar 8, 2021 | Results announced 8-K | Read ↗ |
| Jan 13, 2021 | Results announced 8-K | Read ↗ |
| Dec 22, 2020 | Material agreement 8-K | Read ↗ |
| Nov 9, 2020 | Quarterly report 10-Q | Read ↗ |
| Nov 9, 2020 | Results announced 8-K | Read ↗ |
| Aug 20, 2020 | Executive or director change 8-K | Read ↗ |
| Aug 10, 2020 | Quarterly report 10-Q | Read ↗ |
| Aug 10, 2020 | Results announced 8-K | Read ↗ |
| Jun 25, 2020 | Share offering 424B4 | Read ↗ |
| Jun 22, 2020 | Share offering S-1 | Read ↗ |
| Jun 9, 2020 | Shareholder vote 8-K | Read ↗ |
| Jun 2, 2020 | Executive or director change 8-K | Read ↗ |
| May 28, 2020 | Executive or director change 8-K | Read ↗ |
| May 11, 2020 | Quarterly report 10-Q | Read ↗ |
| May 11, 2020 | Results announced 8-K | Read ↗ |
| Apr 1, 2020 | Executive or director change 8-K | Read ↗ |
| Mar 10, 2020 | Annual report 10-K | Read ↗ |
| Mar 10, 2020 | Results announced 8-K | Read ↗ |
| Mar 5, 2020 | Debt acceleratedMaterial agreement 8-K | Read ↗ |
| Jan 9, 2020 | Results announced 8-K | Read ↗ |
| Dec 19, 2019 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Nov 14, 2019 | Results announced 8-K | Read ↗ |
| Nov 12, 2019 | Quarterly report 10-Q | Read ↗ |
| Nov 12, 2019 | Results announced 8-K | Read ↗ |
| Sep 3, 2019 | Quarterly report 10-Q | Read ↗ |
| Sep 3, 2019 | Results announced 8-K | Read ↗ |
| Jul 29, 2019 | Unregistered share sale 8-K | Read ↗ |
| Jul 26, 2019 | Share offering 424B4 | Read ↗ |
| Jun 26, 2019 | Share offering S-1 | Read ↗ |
Source: Castle Biosciences Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on CSTL
Company overviewEverything on CSTL in one place, with the price.Insider tradingWhat CSTL's own officers and directors buy and sell.Planned salesSales CSTL insiders have filed notice of.Executive payWhat CSTL awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in CSTL.Funds holding itWhich funds and ETFs hold CSTL, and how big a bet.LobbyingWhat CSTL spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on CSTL's account, and who they worked for.Federal contractsWhat federal agencies pay CSTL.PatentsWhat CSTL is filing at the patent office.